相关实验视频

Updated: Mar 15, 2026

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells

Published on: January 5, 2018

在患者衍生的外周血液单核细胞中精确的CRISPR介导编辑TGFBIR555W突变

Burak Dagdelen¹, Hilal Arikoglu¹, Dudu Erkoc-Kaya¹

¹Department of Medical Biology, Faculty of Medicine, Selçuk University, 42130 Konya, Türkiye.

International journal of molecular sciences

|March 14, 2026

概括

在CRISPR/Cas9基因编辑中,成功地纠正了R555W突变,该突变在患者细胞中导致1型颗粒状角膜缩. 这项概念验证研究证明了潜在的未来疗法的精确编辑.

科学领域:

眼科医生眼科眼科
遗传学遗传学是一个
分子生物学分子生物学

背景情况:

转化生长因子β诱导 (TGFBI) 基因中的70多个突变导致遗传角膜变.
R555W突变是1型颗粒状角膜缩症 (GCD1) 的主要原因,导致视力受损.

研究的目的:

评估使用CRISPR/Cas9基因编辑来纠正GCD1患者外周血液单核细胞 (PBMCs) 中R555W突变的技术可行性.

主要方法:

克里斯普尔/卡斯9组件 (sgRNAs和ssODN捐赠者) 被设计并共同转移到患者的PBMC中.
通过流式细胞计量 (GFP阳性细胞) 丰富了细胞以获得成功的转染.
使用高分辨率化 (HRM) 分析评估编辑效率,并通过下一代测序 (NGS) 验证.

主要成果:

sgRNA3-ssODN3组合显示出最有前途的结果.
下一代测序证实,在丰富的GFP阳性细胞群中,同质导向的修复效率为98.2%.
这表明在目标细胞内精确有效地进行基因组编辑.

结论:

这项研究为CRISPR/Cas9介导的GCD1 R555W突变的纠正提供了技术概念验证.
虽然PBMCs不是疾病相关的细胞类型,但这种框架可以指导对角膜疾病的基因编辑策略的优化.
对角膜模型进行进一步的研究是有必要的,以评估临床适用性.

关键词:

这就是CRISPR/Cas9的作用.在R555W突变中.美国联邦调查局TGFBI 基因组编辑基因组编辑颗粒状角膜发育不良症角膜发育不良症同质性导向的维修是指导维修.周围血液中的单核细胞.

更多相关视频

Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development

Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development

Published on: March 5, 2017

CRISPR/Cas9 Ribonucleoprotein-mediated Precise Gene Editing by Tube Electroporation

CRISPR/Cas9 Ribonucleoprotein-mediated Precise Gene Editing by Tube Electroporation

Published on: June 20, 2019

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...